1. |
Koyama R. Cellular and molecular mechanisms underlying aberrant network reorganization in the epileptic brain. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan, 2013, 134(11): 1171-1177.
|
2. |
Chen LL, Feng HF, Mao XX, et al. One hour of pilocarpine-induced status epilepticus is sufficient to develop chronic epilepsy in mice, and is associated with mossy fiber sprouting but not neuronal death. Neuroscience Bulletin, 2013, 29(3): 295-302.
|
3. |
Huang WJ, Tian FF, Chen JM, et al. GSK?3β may be involved in hippocampal mossy fiber sprouting in the pentylenetetrazole?kindling model. Molecular Medicine Reports, 2013, 8(5): 1337-1342.
|
4. |
Dyhrfjeld-Johnsen J, Santhakumar V, Morgan RJ, et al. Topological determinants of epileptogenesis in large-scale structural and functional models of the dentate gyrus derived from experimental data. Journal of Neurophysiology, 2007, 97(2): 1566-1587.
|
5. |
Sloviter RS, Zappone CA, Harvey BD, et al. Kainic acid‐induced recurrent mossy fiber innervation of dentate gyrus inhibitory interneurons: possible anatomical substrate of granule cell hyperinhibition in chronically epileptic rats. Journal of Comparative Neurology, 2006, 494(6): 944-960.
|
6. |
Lin H, Huang Y, Wang Y, et al. Spatiotemporal profile of N cadherin expression in the mossy fiber sprouting and synaptic plasticity following seizures. Mol Cell Biochem, 2011, 358(45): 201 205.
|
7. |
Thomas GM, Huganir RL. MAPK cascade signalling and synaptic plasticity. Nature Reviews Neuroscience, 2004, 5(3): 173-183.
|
8. |
Dulla CG. More than mTOR? Novel roles for MEK-ERK1/2 and FLNA in tuberous sclerosis complex. Epilepsy Currents, 2015, 15(4): 221-222.
|
9. |
Jiang G, Wang W, Cao Q, et al. Insulin growth factor-1 (IGF-1) enhances hippocampal excitatory and seizure activity through IGF-1 receptor-mediated mechanisms in the epileptic brain. Clinical Science, 2015, 129(12): 1047-1060.
|
10. |
Glazova MV, Nikitina LS, Hudik KA, et al. Inhibition of ERK1/2 signaling prevents epileptiform behavior in rats prone to audiogenic seizures. Journal of Neurochemistry, 2015, 132(2): 218-229.
|
11. |
Zu-Cai Xu, Yang-Mei Chen, Ping Xu, et al. Epileptiform Discharge Upregulates P-Erk1/2, Growth-Associated Protein 43 and Synaptophysin in Cultured Rat Hippocampal Neurons. Seizure, 2009, 18 (9): 680-685.
|
12. |
Orlova KA, Crino PB. The tuberous sclerosis complex. Annals of the New York Academy of Sciences, 2010, 1184(1): 87-105.
|
13. |
Goto J, Talos DM, Klein P, et al. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proceedings of the National Academy of Sciences, 2011, 108(45): E1070-E1079.
|
14. |
Zhang L, Bartley CM, Gong X, et al. MEK-ERK1/2-dependent FLNA overexpression promotes abnormal dendritic patterning in tuberous sclerosis independent of mTOR. Neuron, 2014, 84(1): 78-91.
|
15. |
Alhaj MW, Zaitone SA, Moustafa YM. Fluvoxamine alleviates seizure activity and downregulates hippocampal GAP-43 expression in pentylenetetrazole-kindled mice: role of 5-HT3 receptors. Behavioural Pharmacology, 2015, 26(4): 369-382.
|
16. |
Latchney SE, Masiulis I, Zaccaria KJ, et al. Developmental and adult GAP-43 deficiency in mice dynamically alters hippocampal neurogenesis and mossy fiber volume. Developmental Neuroscience, 2014, 36(1): 44-63.
|
17. |
Decker JM, Krüger L, Sydow A, et al. Pro-aggregant Tau impairs mossy fiber plasticity due to structural changes and Ca dysregulation. Acta Neuropathologica Communications, 2015, 1(3): 1-18.
|
18. |
Kandratavicius L, Monteiro MR, Assirati Jr JA, et al. Neurotrophins in mesial temporal lobe epilepsy with and without psychiatric comorbidities. Journal of Neuropathology & Experimental Neurology, 2013, 72(11): 1029-1042.
|
19. |
Xu ZC, Chen YM, Xu P, et al. Epileptiform discharge upregulates p-ERK1/2, growth-associated protein 43 and synaptophysin in cultured rat hippocampal neurons. Seizure, 2009, 18(10): 680-685.
|
20. |
Hu B, Liu C, Bramlett H, et al. Changes in trkB-ERK1/2-CREB/Elk-1 pathways in hippocampal mossy fiber organization after traumatic brain injury. Journal of Cerebral Blood Flow & Metabolism, 2004, 24(8): 934.
|
21. |
Shomit Sengupta, Timothy R Peterson, David M Sabatini. Regulation of the mtor complex 1 pathway by nutrients, growth factors, and stress. Molecular Cell, 2010, 40 (21): 310-322.
|
22. |
Catherine A Vickers, Kirsten S Dickson, David JA Wyllie. Induction and maintenance of late-phase long-term potentiation in isolated dendrites of rat hippocampal ca1 pyramidal neurones. The Journal of Physiology, 2005, 568 (17): 803-813.
|
23. |
Yunfei Huang, Bingnan N Kang, Jing Tian, et al. The Cationic Amino Acid Transporters Cat1 and Cat3 Mediate Nmda Receptor Activation-Dependent Changes in Elaboration of Neuronal Proces Via the Mammalian Target of Rapamycin Mtor Pathway. The Journal of Neuroscience, 2007, 27 (10): 449-458.
|
24. |
Russo E, Citraro R, Donato G, et al. mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy. Neuropharmacology, 2013, 69(12): 25-36.
|
25. |
Wong M. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia, 2010, 51(1): 27-36.
|
26. |
Wang SJ, Bo QY, Zhao XH, et al. Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling. Brain Research, 2013, 1492(1): 122-129.
|
27. |
Tang H, Long H, Zeng C, et al. Rapamycin suppresses the recurrent excitatory circuits of dentate gyrus in a mouse model of temporal lobe epilepsy. Biochemical and Biophysical Research Communications, 2012, 420(1): 199-204.
|
28. |
Zhou J, Blundell J, Ogawa S, et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. The Journal of Neuroscience, 2009, 29(6): 1773-1783.
|
29. |
Meikle L, Pollizzi K, Egnor A, et al. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. The Journal of Neuroscience, 2008, 28(21): 5422-5432.
|
30. |
Buckmaster PS, Ingram EA, Wen X. Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy. The Journal of Neuroscience, 2009, 29(25): 8259-8269.
|
31. |
Ling-Hui Zeng, Nicholas R Rensing, Michael Wong. The Mammalian Target of Rapamycin Signaling Pathway Mediates Epileptogenesis in a Model of Temporal Lobe Epilepsy. The Journal of Neuroscience, 2009, 29 (20): 6964-6972.
|
32. |
Felicia H Lew, Paul S Buckmaster. Is There a Critical Period for Mossy Fiber Sprouting in a Mouse Model of Temporal Lobe Epilepsy?. Epilepsia, 2011, 52 (11): 2326-2332.
|
33. |
Haiyun Tang, Hongyu Long, Chang Zeng, et al. Rapamycin Suppresses the Recurrent Excitatory Circuits of Dentate Gyrus in a Mouse Model of Temporal Lobe Epilepsy. Biochemical and Biophysical Research Communications, 2012, 420 (32): 199-204.
|
34. |
Jonas Dyhrfjeld-Johnsen, Vijayalakshmi Santhakumar, Robert J Morgan, et al. Topological Determinants of Epileptogenesis in Large-Scale Structural and Functional Models of the Dentate Gyrus Derived from Experimental Data. Journal of Neurophysiology, 2007, 97 (11): 1566-1587.
|
35. |
Kron MM, Zhang H, Parent JM. The developmental stage of dentate granule cells dictates their contribution to seizure-induced plasticity. The Journal of Neuroscience, 2010, 30(6): 2051-2059.
|
36. |
Lew FH, Buckmaster PS. Is there a critical period for mossy fiber sprouting in a mouse model of temporal lobe epilepsy? Epilepsia, 2011, 52(12): 2326-2332.
|
37. |
Heng K, Haney MM, Buckmaster PS. High‐dose rapamycin blocks mossy fiber sprouting but not seizures in a mouse model of temporal lobe epilepsy. Epilepsia, 2013, 54(9): 1535-1541.
|
38. |
Huang X, Zhang H, Yang J, et al. Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy. Neurobiology of Disease, 2010, 40(1): 193-199.
|
39. |
Zeng L-H, Rensing NR, Wong M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. The Journal of Neuroscience, 2009, 29(21): 6964-6972.
|
40. |
Sliwa A, Plucinska G, Bednarczyk J, et al. Post-treatment with rapamycin does not prevent epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy. Neuroscience Letters, 2012, 509(2): 105-109.
|